Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Conclusions:
CDK11 and CK2 expression are individually essential for breast cancer cell survival, including TNBC. These genes serve as promising new targets for therapeutic development in breast cancer.
Source: Breast Cancer Research - Category: Cancer & Oncology Authors: Betsy KrenGretchen UngerMd AbedinRachel VogelChristine HenzlerKhalil AhmedJaneen Trembley Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Genetics | Nanotechnology | Statistics